| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Virus Replication | 51 | 2021 | 14331 | 1.76 | Why? |
| Antiviral Agents | 64 | 2021 | 41703 | 1.39 | Why? |
| Chikungunya virus | 13 | 2019 | 339 | 1.36 | Why? |
| Amides | 7 | 2021 | 1864 | 1.13 | Why? |
| Hepacivirus | 8 | 2018 | 1509 | 1.06 | Why? |
| Hepatitis E virus | 6 | 2017 | 306 | 1.03 | Why? |
| RNA Virus Infections | 3 | 2018 | 231 | 0.94 | Why? |
| Rabies virus | 2 | 2017 | 92 | 0.84 | Why? |
| Pyrazines | 7 | 2020 | 1783 | 0.84 | Why? |
| Hydroxylamines | 1 | 2021 | 182 | 0.82 | Why? |
| Cytidine | 1 | 2021 | 219 | 0.79 | Why? |
| Rabies | 2 | 2017 | 113 | 0.78 | Why? |
| 1-Phosphatidylinositol 4-Kinase | 1 | 2018 | 19 | 0.77 | Why? |
| Hepatitis E | 4 | 2017 | 319 | 0.75 | Why? |
| Drug Design | 11 | 2021 | 2627 | 0.67 | Why? |
| Cysteine Proteinase Inhibitors | 2 | 2021 | 675 | 0.67 | Why? |
| Drug Stability | 2 | 2017 | 236 | 0.65 | Why? |
| Neurons | 3 | 2019 | 864 | 0.65 | Why? |
| Excipients | 1 | 2017 | 118 | 0.61 | Why? |
| Poliovirus Vaccine, Oral | 1 | 2017 | 95 | 0.60 | Why? |
| Benzimidazoles | 1 | 2018 | 275 | 0.60 | Why? |
| Euphorbiaceae | 3 | 2019 | 8 | 0.59 | Why? |
| Disease Models, Animal | 13 | 2021 | 10998 | 0.59 | Why? |
| Glutathione | 1 | 2017 | 280 | 0.57 | Why? |
| Enterovirus A, Human | 6 | 2019 | 180 | 0.56 | Why? |
| Caliciviridae Infections | 1 | 2017 | 229 | 0.55 | Why? |
| Post-Exposure Prophylaxis | 2 | 2018 | 472 | 0.53 | Why? |
| Enterovirus | 4 | 2020 | 402 | 0.53 | Why? |
| Norovirus | 1 | 2017 | 294 | 0.52 | Why? |
| Enterovirus Infections | 7 | 2019 | 404 | 0.51 | Why? |
| Cricetinae | 10 | 2021 | 3344 | 0.50 | Why? |
| Cell Line | 20 | 2021 | 12040 | 0.49 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2017 | 584 | 0.47 | Why? |
| Enterovirus B, Human | 3 | 2017 | 124 | 0.46 | Why? |
| Zika Virus | 4 | 2019 | 1924 | 0.44 | Why? |
| Itraconazole | 3 | 2021 | 135 | 0.44 | Why? |
| DNA Replication | 4 | 2018 | 121 | 0.42 | Why? |
| RNA Viruses | 3 | 2018 | 824 | 0.42 | Why? |
| Vero Cells | 24 | 2021 | 14117 | 0.41 | Why? |
| Animals | 54 | 2021 | 78931 | 0.39 | Why? |
| Ribavirin | 4 | 2017 | 1182 | 0.38 | Why? |
| Phorbol Esters | 2 | 2019 | 14 | 0.38 | Why? |
| Mesocricetus | 7 | 2021 | 1847 | 0.37 | Why? |
| Interferons | 2 | 2018 | 2885 | 0.36 | Why? |
| STAT2 Transcription Factor | 2 | 2020 | 141 | 0.36 | Why? |
| Adenosine Monophosphate | 3 | 2021 | 5652 | 0.35 | Why? |
| Alanine | 3 | 2021 | 5687 | 0.35 | Why? |
| Enzyme Inhibitors | 4 | 2019 | 1881 | 0.35 | Why? |
| Hepatitis B virus | 5 | 2017 | 882 | 0.35 | Why? |
| Pyrroles | 3 | 2021 | 292 | 0.34 | Why? |
| Nucleosides | 5 | 2018 | 221 | 0.34 | Why? |
| Chloroquine | 4 | 2021 | 3152 | 0.34 | Why? |
| Hepatocytes | 4 | 2018 | 549 | 0.34 | Why? |
| Coronavirus NL63, Human | 2 | 2015 | 669 | 0.33 | Why? |
| Poliovirus | 3 | 2017 | 109 | 0.33 | Why? |
| Temperature | 1 | 2017 | 2305 | 0.32 | Why? |
| Capsid Proteins | 3 | 2019 | 365 | 0.32 | Why? |
| Diterpenes | 2 | 2018 | 157 | 0.31 | Why? |
| IMP Dehydrogenase | 1 | 2005 | 13 | 0.30 | Why? |
| Inhibitory Concentration 50 | 5 | 2021 | 907 | 0.30 | Why? |
| Quinolines | 2 | 2021 | 403 | 0.30 | Why? |
| High-Throughput Screening Assays | 3 | 2021 | 1783 | 0.29 | Why? |
| Parainfluenza Virus 3, Human | 1 | 2005 | 67 | 0.29 | Why? |
| Small Molecule Libraries | 4 | 2018 | 1060 | 0.29 | Why? |
| Structure-Activity Relationship | 11 | 2018 | 2219 | 0.29 | Why? |
| Rhinovirus | 4 | 2018 | 979 | 0.28 | Why? |
| Neovascularization, Pathologic | 2 | 2018 | 305 | 0.28 | Why? |
| Chikungunya Fever | 3 | 2017 | 345 | 0.28 | Why? |
| Viral Nonstructural Proteins | 7 | 2021 | 4810 | 0.27 | Why? |
| Microbial Sensitivity Tests | 12 | 2021 | 2886 | 0.26 | Why? |
| Yellow fever virus | 1 | 2005 | 205 | 0.25 | Why? |
| Plant Extracts | 3 | 2018 | 1514 | 0.24 | Why? |
| Dengue Virus | 3 | 2019 | 910 | 0.24 | Why? |
| Combinatorial Chemistry Techniques | 2 | 2020 | 54 | 0.23 | Why? |
| Substrate Specificity | 2 | 2021 | 639 | 0.23 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.23 | Why? |
| Nucleotidyltransferases | 1 | 2021 | 77 | 0.22 | Why? |
| Cytochrome P-450 CYP3A Inhibitors | 2 | 2020 | 256 | 0.22 | Why? |
| Mice | 16 | 2020 | 21357 | 0.21 | Why? |
| Furans | 1 | 2021 | 156 | 0.21 | Why? |
| Lactams | 1 | 2020 | 50 | 0.21 | Why? |
| Antibodies, Monoclonal | 6 | 2021 | 8041 | 0.20 | Why? |
| Host-Parasite Interactions | 1 | 2020 | 112 | 0.20 | Why? |
| Bunyaviridae | 1 | 2019 | 22 | 0.20 | Why? |
| Phenanthrenes | 1 | 2019 | 87 | 0.20 | Why? |
| Stilbenes | 1 | 2021 | 113 | 0.20 | Why? |
| Cimicifuga | 1 | 2018 | 2 | 0.19 | Why? |
| Boraginaceae | 1 | 2018 | 3 | 0.19 | Why? |
| Phenylacetates | 1 | 2018 | 4 | 0.19 | Why? |
| Rhadinovirus | 1 | 2018 | 7 | 0.19 | Why? |
| Molecular Structure | 7 | 2018 | 1539 | 0.19 | Why? |
| 2-Aminopurine | 1 | 2018 | 1 | 0.19 | Why? |
| Oximes | 1 | 2018 | 51 | 0.19 | Why? |
| Receptors, CCR6 | 1 | 2018 | 45 | 0.19 | Why? |
| Serial Passage | 1 | 2018 | 126 | 0.19 | Why? |
| Chemokine CCL20 | 1 | 2018 | 47 | 0.19 | Why? |
| Viral Proteins | 7 | 2021 | 7370 | 0.19 | Why? |
| Triazines | 1 | 2021 | 246 | 0.19 | Why? |
| Microsomes, Liver | 1 | 2018 | 96 | 0.19 | Why? |
| Adenine | 2 | 2017 | 463 | 0.19 | Why? |
| Luciferases | 2 | 2018 | 378 | 0.19 | Why? |
| Yellow Fever Vaccine | 1 | 2020 | 198 | 0.19 | Why? |
| Magnoliopsida | 1 | 2018 | 36 | 0.19 | Why? |
| Mannitol | 1 | 2017 | 34 | 0.18 | Why? |
| para-Aminobenzoates | 1 | 2017 | 2 | 0.18 | Why? |
| Nerve Tissue Proteins | 1 | 2021 | 319 | 0.18 | Why? |
| Benzylidene Compounds | 1 | 2018 | 26 | 0.18 | Why? |
| Succinates | 1 | 2018 | 79 | 0.18 | Why? |
| Flavivirus Infections | 1 | 2018 | 81 | 0.18 | Why? |
| Caffeic Acids | 1 | 2018 | 54 | 0.18 | Why? |
| Organic Anion Transporters, Sodium-Dependent | 1 | 2017 | 26 | 0.18 | Why? |
| Carcinoma, Hepatocellular | 2 | 2018 | 1222 | 0.18 | Why? |
| Peptidomimetics | 1 | 2020 | 202 | 0.18 | Why? |
| Antimalarials | 3 | 2021 | 2505 | 0.18 | Why? |
| Euphorbia | 1 | 2017 | 14 | 0.18 | Why? |
| Neutrophil Activation | 1 | 2021 | 510 | 0.18 | Why? |
| Adenosine | 2 | 2021 | 509 | 0.17 | Why? |
| Protein Kinase C-alpha | 1 | 2017 | 12 | 0.17 | Why? |
| Hydrazines | 1 | 2018 | 68 | 0.17 | Why? |
| Cathepsin L | 1 | 2021 | 566 | 0.17 | Why? |
| HIV-2 | 2 | 2016 | 92 | 0.17 | Why? |
| Drug Resistance, Viral | 3 | 2018 | 1083 | 0.17 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2020 | 290 | 0.17 | Why? |
| Protein Kinase C | 1 | 2016 | 58 | 0.17 | Why? |
| Symporters | 1 | 2017 | 80 | 0.17 | Why? |
| Receptors, Steroid | 1 | 2017 | 31 | 0.17 | Why? |
| Heterocyclic Compounds | 1 | 2017 | 64 | 0.17 | Why? |
| Genome, Human | 1 | 2021 | 400 | 0.17 | Why? |
| HeLa Cells | 5 | 2020 | 1303 | 0.17 | Why? |
| Humans | 77 | 2021 | 930598 | 0.17 | Why? |
| Bronchoalveolar Lavage | 1 | 2021 | 603 | 0.16 | Why? |
| Organophosphonates | 2 | 2011 | 85 | 0.16 | Why? |
| Interferon Regulatory Factors | 1 | 2017 | 141 | 0.16 | Why? |
| Thiophenes | 1 | 2017 | 78 | 0.16 | Why? |
| In Vitro Techniques | 2 | 2017 | 1027 | 0.16 | Why? |
| Triazoles | 1 | 2021 | 440 | 0.16 | Why? |
| Genome, Viral | 3 | 2017 | 13157 | 0.16 | Why? |
| Lysine | 1 | 2017 | 153 | 0.16 | Why? |
| Flavivirus | 1 | 2018 | 182 | 0.16 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2020 | 449 | 0.16 | Why? |
| Sexually Transmitted Diseases, Viral | 1 | 2018 | 115 | 0.16 | Why? |
| Herpesviridae Infections | 1 | 2018 | 172 | 0.16 | Why? |
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 113 | 0.16 | Why? |
| Microbial Viability | 2 | 2017 | 406 | 0.16 | Why? |
| Liver Neoplasms | 2 | 2018 | 1666 | 0.16 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.15 | Why? |
| Cardiovirus | 1 | 2015 | 5 | 0.15 | Why? |
| Administration, Intravenous | 1 | 2020 | 1115 | 0.15 | Why? |
| Adenosine Diphosphate Ribose | 1 | 2016 | 126 | 0.15 | Why? |
| Dendrimers | 1 | 2016 | 104 | 0.15 | Why? |
| Central Nervous System Infections | 1 | 2018 | 158 | 0.15 | Why? |
| Herpesvirus 6, Human | 1 | 1998 | 162 | 0.15 | Why? |
| Acyclovir | 2 | 2015 | 154 | 0.15 | Why? |
| Plants | 1 | 2018 | 247 | 0.15 | Why? |
| MAP Kinase Signaling System | 1 | 2018 | 360 | 0.15 | Why? |
| Neuroglia | 1 | 2016 | 130 | 0.15 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2018 | 265 | 0.15 | Why? |
| Cross Reactions | 3 | 2021 | 4374 | 0.15 | Why? |
| Biological Assay | 1 | 2018 | 367 | 0.15 | Why? |
| Methyltransferases | 1 | 2021 | 720 | 0.15 | Why? |
| Virus Internalization | 5 | 2021 | 7921 | 0.15 | Why? |
| Coxsackievirus Infections | 1 | 2015 | 71 | 0.15 | Why? |
| Coronavirus 229E, Human | 4 | 2021 | 1241 | 0.14 | Why? |
| Tryptophan | 1 | 2016 | 218 | 0.14 | Why? |
| Vaccines, Attenuated | 1 | 2020 | 952 | 0.14 | Why? |
| Protein Multimerization | 1 | 2021 | 1336 | 0.14 | Why? |
| Models, Molecular | 8 | 2021 | 7616 | 0.14 | Why? |
| Herpesvirus 1, Human | 1 | 1998 | 286 | 0.14 | Why? |
| Intestine, Small | 1 | 2017 | 336 | 0.14 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.14 | Why? |
| Epithelial Cells | 3 | 2021 | 3508 | 0.13 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.13 | Why? |
| Gene Expression | 3 | 2021 | 3332 | 0.13 | Why? |
| Benzamides | 1 | 2017 | 421 | 0.13 | Why? |
| Pyrrolidines | 1 | 2017 | 558 | 0.13 | Why? |
| Genome-Wide Association Study | 1 | 2021 | 1648 | 0.13 | Why? |
| HIV-1 | 4 | 2016 | 3365 | 0.13 | Why? |
| Fluorescent Dyes | 2 | 2020 | 536 | 0.13 | Why? |
| Blood-Brain Barrier | 1 | 2017 | 531 | 0.13 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.13 | Why? |
| Genotype | 4 | 2018 | 4697 | 0.13 | Why? |
| Arthritis | 1 | 2017 | 288 | 0.13 | Why? |
| Genetic Vectors | 1 | 2020 | 1600 | 0.13 | Why? |
| Polyproteins | 1 | 2016 | 814 | 0.13 | Why? |
| RNA, Viral | 12 | 2021 | 32276 | 0.13 | Why? |
| Protein Processing, Post-Translational | 1 | 2016 | 634 | 0.13 | Why? |
| Pyrimidines | 1 | 2021 | 1557 | 0.12 | Why? |
| Cell Line, Tumor | 5 | 2021 | 3608 | 0.12 | Why? |
| Purines | 1 | 1998 | 816 | 0.12 | Why? |
| Drug Discovery | 4 | 2018 | 3092 | 0.11 | Why? |
| Monocytes | 2 | 2021 | 2978 | 0.11 | Why? |
| CRISPR-Cas Systems | 1 | 2021 | 1397 | 0.11 | Why? |
| Viral Tropism | 2 | 2019 | 1329 | 0.11 | Why? |
| Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.11 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.11 | Why? |
| Betacoronavirus | 10 | 2021 | 204454 | 0.11 | Why? |
| Imidazoles | 1 | 2017 | 631 | 0.11 | Why? |
| Organophosphorus Compounds | 1 | 2010 | 53 | 0.11 | Why? |
| Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.11 | Why? |
| Viral Load | 7 | 2021 | 15850 | 0.11 | Why? |
| Sofosbuvir | 1 | 2015 | 518 | 0.11 | Why? |
| Viral Vaccines | 3 | 2021 | 7560 | 0.10 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.10 | Why? |
| Single-Cell Analysis | 1 | 2021 | 2450 | 0.10 | Why? |
| Cysteine Endopeptidases | 4 | 2020 | 1557 | 0.10 | Why? |
| Indoles | 1 | 2018 | 1243 | 0.10 | Why? |
| Mutation | 5 | 2021 | 12376 | 0.10 | Why? |
| Sulfonamides | 1 | 2018 | 1294 | 0.10 | Why? |
| Cell Death | 1 | 2012 | 536 | 0.10 | Why? |
| Recombinant Proteins | 1 | 2020 | 3786 | 0.10 | Why? |
| Membrane Glycoproteins | 1 | 2019 | 2273 | 0.10 | Why? |
| Clinical Trials as Topic | 2 | 2020 | 7330 | 0.10 | Why? |
| Cytokines | 3 | 2021 | 15010 | 0.10 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2010 | 239 | 0.10 | Why? |
| Hepatitis B | 1 | 2017 | 888 | 0.10 | Why? |
| Protein Conformation, alpha-Helical | 2 | 2021 | 530 | 0.09 | Why? |
| Antibodies, Viral | 6 | 2021 | 51949 | 0.09 | Why? |
| Teicoplanin | 1 | 2011 | 191 | 0.09 | Why? |
| Glycopeptides | 1 | 2011 | 199 | 0.09 | Why? |
| Dengue | 2 | 2018 | 1565 | 0.09 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.09 | Why? |
| Gene Expression Regulation | 2 | 2021 | 4020 | 0.09 | Why? |
| Signal Transduction | 3 | 2020 | 7207 | 0.09 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.09 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.09 | Why? |
| Zika Virus Infection | 2 | 2019 | 1920 | 0.09 | Why? |
| Hydroxychloroquine | 3 | 2021 | 12447 | 0.09 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.09 | Why? |
| Proteolysis | 1 | 2012 | 751 | 0.09 | Why? |
| Protein Conformation, beta-Strand | 2 | 2020 | 414 | 0.09 | Why? |
| Drug Evaluation, Preclinical | 4 | 2021 | 3347 | 0.09 | Why? |
| Crystallography, X-Ray | 3 | 2020 | 2689 | 0.09 | Why? |
| Pyrazoles | 1 | 2018 | 1791 | 0.09 | Why? |
| Coronavirus Infections | 11 | 2021 | 253789 | 0.09 | Why? |
| Lopinavir | 2 | 2020 | 4308 | 0.09 | Why? |
| Antigens, Viral | 3 | 2021 | 6298 | 0.09 | Why? |
| Cyclophilins | 1 | 2008 | 76 | 0.08 | Why? |
| Primates | 2 | 2020 | 584 | 0.08 | Why? |
| Protease Inhibitors | 2 | 2020 | 3630 | 0.08 | Why? |
| Mice, Inbred C3H | 2 | 2015 | 102 | 0.08 | Why? |
| Virus Inactivation | 1 | 2017 | 1139 | 0.08 | Why? |
| Coronavirus | 4 | 2021 | 18339 | 0.08 | Why? |
| Amino Acid Motifs | 2 | 2020 | 620 | 0.08 | Why? |
| Cystic Fibrosis | 1 | 2017 | 1104 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.08 | Why? |
| Protein Kinase Inhibitors | 1 | 2017 | 1585 | 0.08 | Why? |
| Magnetic Resonance Spectroscopy | 3 | 2019 | 881 | 0.08 | Why? |
| Drug Therapy, Combination | 2 | 2017 | 7268 | 0.08 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.08 | Why? |
| Cell Survival | 1 | 2012 | 1581 | 0.08 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.08 | Why? |
| Hepatitis C | 1 | 2017 | 1514 | 0.08 | Why? |
| Dideoxynucleosides | 1 | 2006 | 92 | 0.08 | Why? |
| Jurkat Cells | 2 | 2021 | 273 | 0.08 | Why? |
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2018 | 277 | 0.07 | Why? |
| Pneumonia, Viral | 9 | 2021 | 243684 | 0.07 | Why? |
| Immunity, Innate | 2 | 2021 | 6570 | 0.07 | Why? |
| Guanosine Triphosphate | 1 | 2005 | 29 | 0.07 | Why? |
| Molecular Docking Simulation | 5 | 2021 | 6902 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.07 | Why? |
| Cytopathogenic Effect, Viral | 2 | 2017 | 635 | 0.07 | Why? |
| Stereoisomerism | 2 | 2017 | 121 | 0.07 | Why? |
| SARS Virus | 5 | 2020 | 13021 | 0.07 | Why? |
| Ribonucleosides | 1 | 2005 | 95 | 0.07 | Why? |
| Cyclosporine | 1 | 2008 | 449 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Cells, Cultured | 3 | 2021 | 5835 | 0.06 | Why? |
| Dose-Response Relationship, Drug | 4 | 2020 | 3776 | 0.06 | Why? |
| Neutralization Tests | 3 | 2021 | 6698 | 0.06 | Why? |
| Drug Synergism | 2 | 2017 | 833 | 0.06 | Why? |
| Host-Pathogen Interactions | 4 | 2021 | 11041 | 0.06 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.06 | Why? |
| Protein Binding | 4 | 2021 | 11430 | 0.06 | Why? |
| Drug Repositioning | 2 | 2021 | 5683 | 0.06 | Why? |
| Mycophenolic Acid | 1 | 2005 | 383 | 0.06 | Why? |
| Virulence | 2 | 2021 | 2172 | 0.06 | Why? |
| Catalytic Domain | 2 | 2020 | 1757 | 0.06 | Why? |
| Biological Products | 1 | 2017 | 2331 | 0.06 | Why? |
| Female | 14 | 2021 | 380317 | 0.06 | Why? |
| Replicon | 2 | 2017 | 232 | 0.06 | Why? |
| MicroRNAs | 1 | 2015 | 1787 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.06 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2021 | 2309 | 0.06 | Why? |
| X-Ray Microtomography | 1 | 2021 | 115 | 0.06 | Why? |
| Peptide Mapping | 1 | 2021 | 112 | 0.06 | Why? |
| Proviruses | 1 | 2021 | 82 | 0.05 | Why? |
| Binding Sites | 3 | 2020 | 6201 | 0.05 | Why? |
| Glutamine | 1 | 2020 | 111 | 0.05 | Why? |
| Antigen-Presenting Cells | 1 | 2021 | 206 | 0.05 | Why? |
| Rats | 2 | 2018 | 2764 | 0.05 | Why? |
| Peptides | 1 | 2012 | 2513 | 0.05 | Why? |
| Ganciclovir | 1 | 2000 | 97 | 0.05 | Why? |
| Simplexvirus | 1 | 2000 | 124 | 0.05 | Why? |
| Oxygen Radical Absorbance Capacity | 1 | 2018 | 1 | 0.05 | Why? |
| Micronucleus Tests | 1 | 2018 | 12 | 0.05 | Why? |
| Parasitic Sensitivity Tests | 1 | 2018 | 10 | 0.05 | Why? |
| Animal Structures | 1 | 2018 | 61 | 0.05 | Why? |
| Gene Expression Profiling | 2 | 2021 | 3788 | 0.05 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 382 | 0.05 | Why? |
| Myocarditis | 1 | 2015 | 2731 | 0.05 | Why? |
| Chemotaxis | 1 | 2018 | 67 | 0.05 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.05 | Why? |
| RNA Caps | 1 | 2021 | 204 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Informatics | 1 | 2019 | 89 | 0.05 | Why? |
| 3T3 Cells | 1 | 2018 | 152 | 0.05 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2021 | 640 | 0.05 | Why? |
| Reunion | 1 | 2018 | 94 | 0.05 | Why? |
| Mice, SCID | 1 | 2019 | 225 | 0.05 | Why? |
| Chemical Phenomena | 1 | 2018 | 22 | 0.05 | Why? |
| Carbon Radioisotopes | 1 | 1998 | 35 | 0.05 | Why? |
| Proof of Concept Study | 1 | 2021 | 696 | 0.05 | Why? |
| Cell Communication | 1 | 2021 | 396 | 0.05 | Why? |
| Histocompatibility Antigens Class II | 1 | 2021 | 383 | 0.05 | Why? |
| Principal Component Analysis | 1 | 2021 | 689 | 0.05 | Why? |
| Up-Regulation | 2 | 2017 | 2249 | 0.04 | Why? |
| Plant Components, Aerial | 1 | 2017 | 12 | 0.04 | Why? |
| Phosphoric Diester Hydrolases | 1 | 1998 | 52 | 0.04 | Why? |
| CHO Cells | 1 | 2020 | 831 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2021 | 556 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.04 | Why? |
| Plasmodium | 1 | 2018 | 74 | 0.04 | Why? |
| Wnt Proteins | 1 | 2017 | 38 | 0.04 | Why? |
| Benzothiazoles | 1 | 2018 | 128 | 0.04 | Why? |
| Circular Dichroism | 1 | 2017 | 154 | 0.04 | Why? |
| Cholestenones | 1 | 2017 | 4 | 0.04 | Why? |
| Microscopy, Electron | 1 | 2020 | 830 | 0.04 | Why? |
| Acetophenones | 1 | 2016 | 7 | 0.04 | Why? |
| Oxadiazoles | 1 | 2017 | 41 | 0.04 | Why? |
| Classification | 1 | 2017 | 55 | 0.04 | Why? |
| Wharton Jelly | 1 | 2017 | 46 | 0.04 | Why? |
| Sulfonic Acids | 1 | 2018 | 205 | 0.04 | Why? |
| Cricetulus | 1 | 2020 | 936 | 0.04 | Why? |
| Tetradecanoylphorbol Acetate | 1 | 2017 | 23 | 0.04 | Why? |
| Halogenation | 1 | 2017 | 51 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2018 | 5814 | 0.04 | Why? |
| Protein Conformation | 2 | 2018 | 4386 | 0.04 | Why? |
| Forests | 1 | 2018 | 132 | 0.04 | Why? |
| Gene Knockout Techniques | 1 | 2018 | 347 | 0.04 | Why? |
| Protein Domains | 2 | 2021 | 6563 | 0.04 | Why? |
| Oxazoles | 1 | 2017 | 75 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2021 | 1236 | 0.04 | Why? |
| Ferric Compounds | 1 | 2018 | 136 | 0.04 | Why? |
| Benzopyrans | 1 | 2016 | 39 | 0.04 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2021 | 691 | 0.04 | Why? |
| Enterovirus D, Human | 1 | 2018 | 96 | 0.04 | Why? |
| Coronavirus OC43, Human | 2 | 2021 | 1157 | 0.04 | Why? |
| Transcription Factor AP-1 | 1 | 2017 | 75 | 0.04 | Why? |
| Membrane Fusion | 1 | 2021 | 713 | 0.04 | Why? |
| HEK293 Cells | 2 | 2021 | 8394 | 0.04 | Why? |
| Spectrometry, Mass, Electrospray Ionization | 1 | 2017 | 159 | 0.04 | Why? |
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 49 | 0.04 | Why? |
| Candida albicans | 1 | 2018 | 217 | 0.04 | Why? |
| Alkaline Phosphatase | 1 | 1998 | 257 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.04 | Why? |
| Exoribonucleases | 1 | 2021 | 455 | 0.04 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 286 | 0.04 | Why? |
| Male | 11 | 2021 | 367725 | 0.04 | Why? |
| Macrophages, Alveolar | 1 | 2021 | 668 | 0.04 | Why? |
| Medicine, Traditional | 1 | 2018 | 189 | 0.04 | Why? |
| Tumor Microenvironment | 1 | 2018 | 264 | 0.04 | Why? |
| Hydrolysis | 1 | 2016 | 160 | 0.04 | Why? |
| Molecular Conformation | 1 | 2017 | 374 | 0.04 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.04 | Why? |
| Virus Latency | 1 | 2018 | 251 | 0.04 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.04 | Why? |
| Glycosylation | 1 | 2020 | 1255 | 0.04 | Why? |
| ErbB Receptors | 1 | 2018 | 320 | 0.04 | Why? |
| Capsid | 1 | 2017 | 197 | 0.04 | Why? |
| Antibody Affinity | 1 | 2021 | 1078 | 0.04 | Why? |
| Macaca fascicularis | 1 | 2020 | 1009 | 0.04 | Why? |
| Transcriptional Activation | 1 | 2017 | 196 | 0.04 | Why? |
| Epitope Mapping | 1 | 2021 | 1240 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2018 | 540 | 0.04 | Why? |
| Quinazolines | 1 | 2016 | 126 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2017 | 5542 | 0.04 | Why? |
| Protein Folding | 1 | 2017 | 270 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2015 | 8843 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2020 | 813 | 0.04 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.04 | Why? |
| Hydrogen Bonding | 1 | 2018 | 599 | 0.04 | Why? |
| Enzyme Activation | 1 | 2017 | 425 | 0.04 | Why? |
| Th17 Cells | 1 | 2021 | 657 | 0.04 | Why? |
| Glycoproteins | 1 | 2020 | 615 | 0.04 | Why? |
| Computer Simulation | 2 | 2021 | 4982 | 0.04 | Why? |
| Arthralgia | 1 | 2017 | 173 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2018 | 987 | 0.04 | Why? |
| Saponins | 1 | 2017 | 171 | 0.04 | Why? |
| Loperamide | 1 | 2014 | 13 | 0.04 | Why? |
| Mutagenesis | 1 | 2017 | 394 | 0.04 | Why? |
| Ferrets | 1 | 2020 | 1201 | 0.03 | Why? |
| Fibroblasts | 2 | 2016 | 839 | 0.03 | Why? |
| Lung | 5 | 2021 | 31049 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.03 | Why? |
| Species Specificity | 1 | 2018 | 1356 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Phosphorylation | 1 | 1998 | 1060 | 0.03 | Why? |
| Thermodynamics | 1 | 2018 | 873 | 0.03 | Why? |
| Dogs | 1 | 2021 | 2529 | 0.03 | Why? |
| Immunoglobulin G | 1 | 2017 | 21571 | 0.03 | Why? |
| Chlorpromazine | 1 | 2014 | 130 | 0.03 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2021 | 1267 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.03 | Why? |
| Feces | 2 | 2018 | 4235 | 0.03 | Why? |
| Mutation, Missense | 1 | 2019 | 863 | 0.03 | Why? |
| Amino Acids | 1 | 2016 | 552 | 0.03 | Why? |
| Cryoelectron Microscopy | 1 | 2020 | 2372 | 0.03 | Why? |
| Safety | 1 | 2020 | 1583 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2018 | 1165 | 0.03 | Why? |
| Spectrometry, Mass, Fast Atom Bombardment | 1 | 2011 | 2 | 0.03 | Why? |
| A549 Cells | 1 | 2018 | 2066 | 0.03 | Why? |
| Extracellular Traps | 1 | 2021 | 1036 | 0.03 | Why? |
| Cell Culture Techniques | 1 | 2017 | 704 | 0.03 | Why? |
| Central Nervous System | 1 | 2017 | 701 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.03 | Why? |
| Plants, Medicinal | 1 | 2018 | 622 | 0.03 | Why? |
| Chronic Disease | 2 | 2017 | 5139 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.03 | Why? |
| Drug Delivery Systems | 1 | 2001 | 1365 | 0.03 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2001 | 1454 | 0.03 | Why? |
| Phytotherapy | 1 | 2018 | 743 | 0.03 | Why? |
| Fluorescent Antibody Technique | 2 | 2011 | 835 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.03 | Why? |
| Immediate-Early Proteins | 1 | 1989 | 44 | 0.03 | Why? |
| Staining and Labeling | 1 | 2011 | 169 | 0.03 | Why? |
| Cytomegalovirus | 2 | 2000 | 600 | 0.03 | Why? |
| Polymerase Chain Reaction | 1 | 2005 | 6740 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| Asia | 1 | 2017 | 2399 | 0.02 | Why? |
| Workflow | 1 | 2019 | 2373 | 0.02 | Why? |
| Phenotype | 1 | 2021 | 4037 | 0.02 | Why? |
| Genes, Reporter | 1 | 2011 | 472 | 0.02 | Why? |
| T-Lymphocytes | 2 | 2015 | 6670 | 0.02 | Why? |
| Influenza A virus | 1 | 2021 | 2234 | 0.02 | Why? |
| Myocytes, Cardiac | 1 | 2015 | 804 | 0.02 | Why? |
| Open Reading Frames | 1 | 2016 | 1898 | 0.02 | Why? |
| Africa | 1 | 2017 | 2986 | 0.02 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.02 | Why? |
| Virus Cultivation | 1 | 2011 | 579 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2011 | 669 | 0.02 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.02 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.02 | Why? |
| Medicine, Chinese Traditional | 1 | 2018 | 2255 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2017 | 3239 | 0.02 | Why? |
| RNA, Complementary | 1 | 2004 | 11 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Colony Count, Microbial | 1 | 2005 | 177 | 0.02 | Why? |
| Drug Approval | 1 | 2014 | 1325 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Skin | 1 | 2016 | 2096 | 0.02 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2005 | 12361 | 0.02 | Why? |
| Neutrophils | 1 | 2021 | 5476 | 0.02 | Why? |
| Anti-HIV Agents | 1 | 2016 | 2209 | 0.02 | Why? |
| Liver | 1 | 2018 | 4007 | 0.02 | Why? |
| Japan | 1 | 2017 | 6653 | 0.02 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.02 | Why? |
| Macrophages | 1 | 2015 | 2784 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 7868 | 0.02 | Why? |
| B-Lymphocytes | 1 | 1998 | 4418 | 0.02 | Why? |
| Lithocholic Acid | 1 | 2001 | 3 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Lactose | 1 | 2001 | 17 | 0.01 | Why? |
| Immunity, Cellular | 1 | 2015 | 3614 | 0.01 | Why? |
| Tumor Cells, Cultured | 1 | 2001 | 254 | 0.01 | Why? |
| Virus Shedding | 1 | 2018 | 5834 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Bromodeoxyuridine | 1 | 2000 | 13 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Flow Cytometry | 1 | 1989 | 2393 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Foscarnet | 1 | 2000 | 13 | 0.01 | Why? |
| France | 1 | 2017 | 12074 | 0.01 | Why? |
| India | 1 | 2018 | 11875 | 0.01 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Lipoproteins, HDL | 1 | 2001 | 154 | 0.01 | Why? |
| Middle Aged | 3 | 2021 | 270681 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Leukocytes, Mononuclear | 1 | 2008 | 2115 | 0.01 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 13720 | 0.01 | Why? |
| Herpesvirus 3, Human | 1 | 2000 | 228 | 0.01 | Why? |
| Cell Proliferation | 1 | 2005 | 1973 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Molecular Dynamics Simulation | 1 | 2010 | 4155 | 0.01 | Why? |
| Drug Resistance, Microbial | 1 | 2000 | 419 | 0.01 | Why? |
| Drug Carriers | 1 | 2001 | 590 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Administration, Oral | 1 | 2000 | 2340 | 0.01 | Why? |
| HIV Infections | 1 | 2016 | 11620 | 0.01 | Why? |
| Time Factors | 2 | 2004 | 31397 | 0.00 | Why? |
| Sensitivity and Specificity | 1 | 2005 | 22971 | 0.00 | Why? |
| Adult | 1 | 2021 | 244371 | 0.00 | Why? |